Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment: ESMO Consensus Recommendations
G. Curigliano, D. Lenihan, M. Fradley, S. Ganatra, A. Barac, A. Blaes, J. Herrmann, C. Porter, A. R. Lyon, P. Lancellotti, A. Patel, J. DeCara, J. Mitchell, E. Harrison, J. Moslehi, R. Witteles, M. G. Calabro, R. Orecchia, E. de Azambuja, J. L. Zamorano, R. Krone, Z. Iakobishvili, J. Carver, S. Armenian, B.Ky, D. Cardinale, C. M. Cipolla, S. Dent & K. Jordan
Ann Oncol (2020); 31(2): 171-190
CARDIONCOLOGY.ORG ABSTRACT:
This ESMO article discusses best practices for the management of patients exposed to potentially cardiotoxic therapy.
It further provides suggestions for prevention, detection and treatment of cardiotoxicity.
© All Rights Reserved